Increasing frequencies of chronic disorders and growing demand for effective therapeutic drugs have positively impacted the market development. Technological advancements in gene editing have meaningfully aided scientists in the research and development of novel drugs, leading to improved utilization of mice models. These models are widely used in research studies of various fields like oncology and immunology. Growing demand for personalized medicines has further controlled to rise in developing the genetically modified humanized mice model market. The Mice Model Market is anticipated to grow at the rate of 7.31% CAGR by 2026.

Research Methodology:

The Mice /model market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology and a unique balance of primary insights. The real-time valuation of the market is an integral part of our forecasting and market sizing methodology. Industry experts and our primary participants have helped to compile related aspects with accurate parametric estimations for a complete study. The primary participants share is given below:

Mice Model Market by Type

• Inbred Mice
• Outbred Mice
• Genetically Engineered Mice
• Hybrid/Congenic Mice
• Others

Mice Model Market by Technology

• CRISPR/CAS9
• Embryonic Stem Cell Injection
• Nuclear Transfer
• Other Technologies

Mice Model Market by Application

• Oncology
• Cardiovascular Studies
• Neurology
• Other Applications

Mice Model Market by Service

• Breeding
• Cryopreservation
• Model in-Licensing
• Genetic Testing
• Other Services

Mice Model Market by Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

The mice model market based on application has been segmented into immunology and inflammation studies, oncology studies, endocrine, metabolic studies, central nervous system studies, genetic studies, infectious disease studies, cardiovascular studies, and other disease studies. The endocrine disease studies are further segmented into diabetes and other endocrine metabolic disease. The oncology segment is anticipated to account for the largest market share in 2020, with the highest development rate.

The mice model market based on services has been segmented into breeding, quarantine, cryopreservation, rederivation, genetic testing, model in-licensing, and other services. Breeding segmented is anticipated to account for the largest market share in 2020, with the highest development rate. This can majorly be ascribed to the growing demand for mice models for drug discovery and development and the subsequent rise in personalized medicine demand.

On the basis of the type of technology used to create transgenic mice, the mice model market is segmented into microinjection, embryonic stem cell injection, CRISPR/Cas9, nuclear transfer, and other technology segments. CRISPR is the most broadly utilized technology and contributed to the largest share of the mice model market in 2020.

North America holds the major share of the mice model market. The large share of the North American region can be attributed to major players operating in the US's mice model market, rising biomedical research in the US, rising preclinical activities by CROs and pharmaceutical companies in the region.

This report includes the profiles of companies that are leading the Mice Model market: Charles River Laboratories, The Jackson Laboratory, Taconic Biosciences, Inc, Envigo, JANVIER LABS, genOway, PolyGene, Crown Biosciences, TransCure Bioservices, Ingenious Targeting Laboratory, Cyagen Biosciences, GVK BIO, The Andersons, Inc, Innovive, Allentown, LLC, FENGSHI Group, Ozgene Pty Ltd, Harbour Biomed.

• This report offers an overall analysis of the Mice Model market growth drivers, restraints, opportunities, and other related challenges.
• This report depicts the market developments such as new product launches, mergers and acquisitions, diversification, and joint ventures of the market players.
• This report also describes all potential segments and sub-segments present in the market to help the companies in strategic business planning.
• This report also gives the regional analysis of the Mice Model market in terms of market penetration across the world.

1. Executive Summary
2. Industry Outlook
   1. Industry Overview
   2. Industry Trends
3. Market Snapshot
   1. Market Definition
   2. Market Outlook
      1. Porter Five Forces
   3. Related Markets
4. Market characteristics
   1. Market Overview
   2. Market Segmentation
   3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
   4. DRO - Impact Analysis
5. Type: Market Size & Analysis
   1. Overview
   2. Inbred Mice
   3. Outbred Mice
   4. Genetically Engineered Mice
   5. Hybrid/Congenic Mice
   6. Others
6. Service: Market Size & Analysis
   1. Overview
   2. Breeding
   3. Cryopreservation
   4. Model in-Licensing
   5. Genetic Testing
   6. Other Services
7. Technology: Market Size & Analysis
   1. Overview
   2. CRISPR/CAS9
   3. Embryonic Stem Cell Injection
   4. Nuclear Transfer
   5. Other Technologies
8. Application: Market Size & Analysis
   1. Overview
   2. Oncology
   3. Cardiovascular Studies
   4. Neurology
   5. Other Applications
9. Geography: Market Size & Analysis
   1. Overview
   2. North America
   3. Europe
   4. Asia Pacific
   5. Rest of the World
10. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
       1. Mergers and Acquisitions, Legal, Awards, Partnerships
       2. Product Launches and execution
11. Vendor Profiles
    1. Taconic Biosciences, Inc.
       1. Overview
       2. Financial Overview
       3. Product offerings
       4. Developments
       5. Business Strategy
    2. The Jackson Laboratory
       1. Overview
       2. Financial Overview
       3. Product offerings
       4. Developments
       5. Business Strategy
    3. Charles River Laboratories
       1. Overview
       2. Financial Overview
       3. Product offerings
       4. Developments
       5. Business Strategy
    4. Ingenious Targeting Laboratory
       1. Overview
       2. Financial Overview
       3. Product offerings
       4. Developments
       5. Business Strategy
    5. JANVIER LABS
       1. Overview
       2. Financial Overview
       3. Product offerings
       4. Developments
       5. Business Strategy
    6. TransCure bioservices
       1. Overview
       2. Financial Overview
       3. Product offerings
       4. Developments
       5. Business Strategy
    7. Envigo
       1. Overview
       2. Financial Overview
       3. Product offerings
       4. Developments
       5. Business Strategy
    8. genOway
       1. Overview
       2. Financial Overview
       3. Product offerings
       4. Developments
       5. Business Strategy
    9. PolyGene
       1. Overview
       2. Financial Overview
       3. Product offerings
       4. Developments
       5. Business Strategy
    10. Crown Biosciences
        1. Overview
        2. Financial Overview
        3. Product offerings
        4. Developments
        5. Business Strategy
12. Companies to Watch
    1. Cyagen Biosciences
       1. Overview
       2. Products & Services
       3. Business Strategy
13. Analyst Opinion
14. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
       1. Data Collation and In-house Estimation
       2. Market Triangulation
       3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations